Proteomics, biomarkers, and HIV-1: A current perspective

Proteomics Clin Appl. 2016 Feb;10(2):110-25. doi: 10.1002/prca.201500002. Epub 2015 Jul 8.

Abstract

Despite more than three decades of extensive research, HIV-1 infection although well controlled with cART, remains incurable. Multifactorial complexity of the viral life-cycle poses great challenges in understanding molecular mechanisms underlying this infection and the development of biomarkers, which we hope will lead us to its eradication. For a more in-depth understanding of how the virus interacts with host target cells, T cells and macrophages, proteomic profiling techniques that offer strategies to investigate the proteome in its entirety were employed. Here, we review proteomic studies related to HIV-1 infection and discuss perspectives and limitations of proteomic and systems biology approaches in future studies.

Keywords: Biomarker; Body fluids; HIV; Macrophage; Systems biology; T cell.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Biomarkers / analysis
  • Biomarkers / metabolism
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / metabolism*
  • Humans
  • Proteomics*
  • Viral Proteins / analysis*
  • Viral Proteins / metabolism

Substances

  • Biomarkers
  • Viral Proteins